LG Energy Solution reported its estimated earnings for the second quarter of 2023.

GC Biopharma announced on the 3rd that it had signed a supply contract with Blau Farmaceutica, a local partner in Brazil, on the 30th of last month for its immunoglobulin blood product, “IVIG-SN 5%.” Through this contract, GC Biopharma will supply $90.84 million(about 119.4 billion won) worth of supplies to Brazil.

SK Telecom will invest $100 million(approximately 130 billion won) in Joby Aviation(hereinafter referred to as Joby), a global UAM(Urban Air Mobility) aircraft manufacturer, and cooperate in the UAM business.

Amorepacific is launching a service called "My Skin Solution" that provides personalized skin management solutions.

VUNO, a medical AI company, has announced that the patent of its core technology, "Method and Device for Supporting Fundus Image Interpretation for Blood Samples," which is essential for healthcare professionals to interpret AI-based fundus image, will be registered in the United States.

CJ CGV is pursuing a capital increase of up to 1 trillion won to stabilize its financial structure and strengthen future business operations.

Samsung Electronics has launched its 89-inch micro-LED display in the Chinese market, aiming to strengthen its presence in the premium segment.

LG Energy Solution is embarking on its first corporate bond issuance since its establishment.

SK Pharmteco, SK’s Contract Development Manufacturing Organization(CDMO) subsidiary completed its second plant in Europe for Cell and Gene Therapy(CGT) and will accelerate its expansion into the global market.

Hanmi Pharm announced two findings from research on LAPSTriple agonist (LAPSTriple) that the company was developing as an innovative new drug for non-alcoholic steatohepatitis (NASH).